Candida Vaginitis. Candidiasis of Vulva and Vagina
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: signs and symptoms of Candida vaginitis, positive direct smear of vaginal discharge Exclusion criteria: pregnant women, low compliance, any drug hypersensitivity, recurrent Candida vaginitis (4 or more Candida vaginitis in a year), consumption of immunosuppressive drug or widespread antibiotics, history of epilepsy, diabetes, heart disease, high blood pressure, thyroid diseases, or advanced arthritis, using other vaginal creams or suppositories during the study period, consumption of systemic antifungal drugs during 4 weeks prior to the study, presence of non-candidal vaginitis, consumption of oral contraceptives.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Discharge. Timepoint: Baseline, 1&2 week after treatment. Method of measurement: Clinical Examination, observation, and medical history.;Pruritus. Timepoint: Baseline, 1&2 week after treatment. Method of measurement: History.;Erythema symptoma. Timepoint: Baseline, 1&2 week after treatment. Method of measurement: Clinical Examination, Observation, and History.;Dysuria Symptom. Timepoint: Baseline, 1&2 week after treatment. Method of measurement: History.;Dysparonia Symptom. Timepoint: Baseline, 1&2 week after treatment. Method of measurement: History.;Wet Smear and Vaginal Culture results. Timepoint: Baseline, 1&2 week after treatment. Method of measurement: Wet Smear and Vaginal Culture. | — |
Countries
Iran (Islamic Republic of)
Contacts
Jondishapour University of Medical Sciences